SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Hikal

Hikal

BSE: 524735 | NSE: HIKAL | ISIN: INE475B01014 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Dec 10, 16:30
734.00
12.15 (+1.68%)
VOLUME 1,442
AVERAGE VOLUME
5-Day 7,306
10-Day 4,170
30-Day 4,234
VOLUME SHOCKER
5-Day 7,306
10-Day 4,170
30-Day 4,234
Prev. Close
721.85
Open Price
730.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 718.00 740.00
52 Wk Low/High 427.20 784.40
LIVE
NSE
Dec 10, 16:30
728.30
10.75 (+1.50%)
VOLUME 4,465
AVERAGE VOLUME
5-Day 23,615
10-Day 14,680
30-Day 14,140
VOLUME SHOCKER
5-Day 23,615
10-Day 14,680
30-Day 14,140
Prev. Close
717.55
Open Price
722.20
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 717.00 736.20
52 Wk Low/High 433.10 790.00
Action in Hikal

No recommendations so far.

What's your call on Hikal today?
Read 1 investor views

MARKET CAP (Rs Cr)
1,206.70
*P/E
35.19
*BOOK VALUE (Rs)
307.73
DIV (%)
45.00%
Market Lot
1
INDUSTRY P/E
23.55
*EPS (TTM)
20.86
*P/C
13.51
*PRICE/BOOK
2.39
DIV YIELD.(%)
0.61%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
50.95 new
DELIVERY AVERAGES
3-Day 47.47%
5-Day 37.17%
8-Day 39.15%
* Based on standalone numbers
Track Hikal on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

18 December 2014

buy

BHEL Dec Fut

Entry Price (Rs)

254.00

Exit Price (Rs)

257.50

Gain (Rs)

4.00

buy

ITC Dec Fut

Entry Price (Rs)

372.00

Exit Price (Rs)

377.50

Gain (Rs)

6.00

buy

CanaraBank Dec Fut

Entry Price (Rs)

428.00

Exit Price (Rs)

432.50

Gain (Rs)

5.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 462.85 730.00  
High Price 474.75 740.00  
Low Price 452.00 718.00  
Last Price 467.80 734.00 56.90
Volume 1,487 1,442 -3.03
Simple Moving Averages
Days BSE NSE
30 721.78 723.01
50 713.20 714.26
150 616.09 617.25
200 582.74 583.64

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Hikal

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Standalone (Sep '14)
(Jun '14)
Net Sales 242.88 190.39
Other Income 0.35 0.83
PBDIT 53.94 37.11
Net Profit 15.25 5.70

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Jun '14)
(In Rs Cr)
Total Share Capital 16.44
Net Worth 505.91
Total Debt 470.37
Net Block 644.14
Investments 3.13
Net Current Assets 267.84
Total Assets 976.28
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 812.75 0.12 932.00 552.50 168,333.85
Lupin 1425.25 2.28 1500.00 882.80 64,023.92
Dr Reddys Labs 3150.50 -0.31 3662.00 2250.00 53,673.76
Cipla 625.10 3.28 671.95 366.70 50,190.61
Cadila Health 1536.95 2.91 1760.00 794.00 31,468.82
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Dec' 13Sep' 13
Promoter68.7768.7768.8368.83
FII4.654.553.203.20
DII9.508.909.828.76
Others17.0817.7818.1519.21
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
717/718, Maker Chambers V,,Nariman Point
City
Mumbai
State
Maharashtra
Pin Code
400021
Tel. No.
022-27574276
Fax No.
022-27574277
REGISTRARS
Name
Universal Capital Securities Pvt. Ltd.
Address
21/25, Shakil Nivas, Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (East)
City
Mumbai - 400093
State
Maharashtra
Tel. No.
022-28207203, 28207204, 28207205, 28257641
Fax No.
022-28262920, 28267207
MANAGEMENT
Name
Designation
Jai Hiremath
Chairman & Managing Director
Sameer Hiremath
Joint Managing Director
Baba Kalyani
Director
Prakash Mehta
Director
Shivkumar Kheny
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

DCB Bank Recommended on Aug 19th 2014

Recommended price 81.00  |  Peak from reco 117.40 36.36%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Hikal

Hikal is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,206.70 crore.The company has reported a standalone sales of Rs 242.88 crore and a Net Profit of Rs 15.25 crore for the quarter ended Sep 2014.

The company management includes Jai Hiremath - Chairman & Managing Director, Sameer Hiremath - Joint Managing Director, Baba Kalyani - Director, Prakash Mehta - Director, Shivkumar Kheny - Director, Kannan Unni - Director, Peter Pollak - Director, Amit Kalyani - Director, Wolfgang Welter - Director, Sugandha Hiremath - Director, C G Kumar - Independent Director, Suguna Ravichandran - Independent Director, Axel Kleemann - Additional Director.

It is listed on the BSE with a BSE Code of 524735 and the NSE with an NSE Code of HIKAL.

Its Registered office is at 717/718, Maker Chambers V,,Nariman Point Mumbai,Maharashtra - 400021.

Their Registrars are Universal Capital Securities Pvt. Ltd.

Quick Links for Hikal
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Hikal